{"id":"https://openalex.org/W3008901682","doi":"https://doi.org/10.1007/s40121-020-00286-6","title":"Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms","display_name":"Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms","publication_year":2020,"publication_date":"2020-02-18","ids":{"openalex":"https://openalex.org/W3008901682","doi":"https://doi.org/10.1007/s40121-020-00286-6","mag":"3008901682","pmid":"https://pubmed.ncbi.nlm.nih.gov/32072491","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7054475"},"language":"en","primary_location":{"id":"doi:10.1007/s40121-020-00286-6","doi":"https://doi.org/10.1007/s40121-020-00286-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-020-00286-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-020-00286-6.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40121-020-00286-6.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024417133","display_name":"Janet Wu","orcid":"https://orcid.org/0000-0002-1825-2877","observed_orcids":["https://orcid.org/0000-0002-1825-2877"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Janet Y. Wu","raw_affiliation_strings":["Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA. wuj5@ccf.org","Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":"https://orcid.org/0000-0002-1825-2877","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA. wuj5@ccf.org","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034288190","display_name":"Pavithra Srinivas","orcid":"https://orcid.org/0000-0001-8225-2620","observed_orcids":["https://orcid.org/0000-0001-8225-2620","https://orcid.org/0009-0004-1909-3515"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavithra Srinivas","raw_affiliation_strings":["Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077074926","display_name":"Jason M. Pogue","orcid":"https://orcid.org/0000-0003-4780-6215","observed_orcids":["https://orcid.org/0000-0003-4780-6215"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason M. Pogue","raw_affiliation_strings":["College of Pharmacy, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5024417133"],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":{"value":5056,"currency":"USD","value_usd":5056},"apc_paid":{"value":5056,"currency":"USD","value_usd":5056},"fwci":2.4575,"has_fulltext":true,"cited_by_count":200,"citation_normalized_percentile":{"value":0.9121447,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"9","issue":"1","first_page":"17","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefiderocol","display_name":"cefiderocol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/siderophore-cephalosporin","display_name":"siderophore cephalosporin","score":0.9300000071525574},{"id":"https://openalex.org/keywords/multidrug-resistant-gram-negative-bacteria","display_name":"multidrug-resistant Gram-negative bacteria","score":0.8659999966621399},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.9200000166893005},{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.9229999780654907},{"id":"https://openalex.org/keywords/carbapenemase","display_name":"carbapenemase","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7720000147819519},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7979999780654907},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/complicated-urinary-tract-infection","display_name":"complicated urinary tract infection","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hospital-acquired-pneumonia","display_name":"nosocomial pneumonia","score":0.8899999856948853},{"id":"https://openalex.org/keywords/enterobacterales","display_name":"Enterobacterales","score":0.9020000100135803},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.7762367129325867},{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.6694215536117554},{"id":"https://openalex.org/C108319773","wikidata":"https://www.wikidata.org/wiki/Q424747","display_name":"Siderophore","level":3,"score":0.5677037239074707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5445920825004578},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.5146897435188293},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.49674469232559204},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.4663998484611511},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.44808638095855713},{"id":"https://openalex.org/C2778368673","wikidata":"https://www.wikidata.org/wiki/Q553220","display_name":"Ertapenem","level":5,"score":0.4316878318786621},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40879157185554504},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.39887145161628723},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3607247769832611},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3343011736869812},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.2431831657886505},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.17384156584739685},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.14484354853630066},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s40121-020-00286-6","doi":"https://doi.org/10.1007/s40121-020-00286-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-020-00286-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-020-00286-6.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7054475","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7054475","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infect Dis Ther","raw_type":"Text"},{"id":"pmid:32072491","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32072491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious diseases and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:014db1f7afaf4df79b0aafe7ab95e551","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/014db1f7afaf4df79b0aafe7ab95e551","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infectious Diseases and Therapy, Vol 9, Iss 1, Pp 17-40 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40121-020-00286-6","doi":"https://doi.org/10.1007/s40121-020-00286-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-020-00286-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-020-00286-6.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3008901682.pdf","grobid_xml":"https://content.openalex.org/works/W3008901682.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W2044678473","https://openalex.org/W2095741521","https://openalex.org/W2103137511","https://openalex.org/W2112203749","https://openalex.org/W2115118328","https://openalex.org/W2198013734","https://openalex.org/W2346730904","https://openalex.org/W2530661320","https://openalex.org/W2534162630","https://openalex.org/W2554894514","https://openalex.org/W2618911885","https://openalex.org/W2683726696","https://openalex.org/W2749795132","https://openalex.org/W2765117954","https://openalex.org/W2766112856","https://openalex.org/W2766370714","https://openalex.org/W2766395453","https://openalex.org/W2767038067","https://openalex.org/W2770431582","https://openalex.org/W2782246563","https://openalex.org/W2786886659","https://openalex.org/W2792918155","https://openalex.org/W2796302271","https://openalex.org/W2884882342","https://openalex.org/W2890501899","https://openalex.org/W2895593384","https://openalex.org/W2897987794","https://openalex.org/W2898144230","https://openalex.org/W2898974554","https://openalex.org/W2899757291","https://openalex.org/W2900180211","https://openalex.org/W2900641309","https://openalex.org/W2900807296","https://openalex.org/W2912906332","https://openalex.org/W2915553362","https://openalex.org/W2936039267","https://openalex.org/W2954782621","https://openalex.org/W2965715014","https://openalex.org/W2965928198","https://openalex.org/W2966291784","https://openalex.org/W2968244461","https://openalex.org/W2975667851","https://openalex.org/W2976002113","https://openalex.org/W2994888542","https://openalex.org/W4237720379"],"related_works":["https://openalex.org/W3092701231","https://openalex.org/W2912906332","https://openalex.org/W3196872974","https://openalex.org/W4402083972","https://openalex.org/W3195627102","https://openalex.org/W3127762568","https://openalex.org/W3033680496","https://openalex.org/W3126925629","https://openalex.org/W3154433526","https://openalex.org/W4223462270"],"abstract_inverted_index":{"Cefiderocol,":[0],"formerly":[1],"S-649266,":[2],"is":[3,99,122],"a":[4,15],"first":[5],"in":[6,103,143,147],"its":[7,32,145],"class,":[8],"an":[9],"injectable":[10],"siderophore":[11,17],"cephalosporin":[12,19],"that":[13],"combines":[14],"catechol-type":[16],"and":[18,27,31,52,63,72,84,98,110,136],"core":[20],"with":[21],"side":[22],"chains":[23],"similar":[24],"to":[25,123,140],"cefepime":[26],"ceftazidime.":[28],"This":[29],"structure":[30],"unique":[33],"mechanism":[34,129],"of":[35,67,91,119,130,138],"action":[36],"confer":[37],"enhanced":[38],"stability":[39],"against":[40],"hydrolysis":[41],"by":[42,113],"many":[43],"\u03b2-lactamases,":[44],"including":[45,76,96],"extended":[46],"spectrum":[47,66],"\u03b2-lactamases":[48],"such":[49,54],"as":[50,55],"CTX-M,":[51],"carbapenemases":[53],"KPC,":[56],"NDM,":[57],"VIM,":[58],"IMP,":[59],"OXA-23,":[60],"OXA-48-like,":[61],"OXA-51-like":[62],"OXA-58.":[64],"Cefiderocol's":[65],"activity":[68],"encompasses":[69],"both":[70],"lactose-fermenting":[71],"non-fermenting":[73],"Gram-negative":[74,115],"pathogens,":[75],"carbapenem-resistant":[77,114],"Enterobacterales.":[78],"Cefiderocol":[79],"recently":[80],"received":[81],"US":[82],"Food":[83],"Drug":[85],"Administration":[86],"approval":[87],"for":[88,107],"the":[89,128],"treatment":[90],"complicated":[92],"urinary":[93],"tract":[94],"infections,":[95],"pyelonephritis,":[97],"currently":[100],"being":[101],"evaluated":[102],"phase":[104],"III":[105],"trials":[106],"nosocomial":[108],"pneumonia":[109],"infections":[111],"caused":[112],"pathogens.":[116],"The":[117],"purpose":[118],"this":[120],"article":[121],"review":[124],"existing":[125],"data":[126],"on":[127],"action,":[131],"microbiology,":[132],"pharmacokinetics,":[133],"pharmacodynamics,":[134],"efficacy,":[135],"safety":[137],"cefiderocol":[139],"assist":[141],"clinicians":[142],"determining":[144],"place":[146],"therapy.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":29},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":37},{"year":2022,"cited_by_count":36},{"year":2021,"cited_by_count":28},{"year":2020,"cited_by_count":18}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-03-06T00:00:00"}
